Ocuphire Pharma is a late clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of retinal and refractive eye disorders.
SEE WHO WE ARE
APX3330 is a twice-a-day oral tablet, designed to inhibit angiogenesis and inflammatory pathways relevant to retinal and choroidal vascular diseases.
Phentolamine Ophthalmic Solution 0.75% Eye Drops is a once-daily preservative-free eye drop formulation designed to reduce pupil size and improve visual acuity.
Feb 23, 2024 8:00am EST
Feb 14, 2024 8:00am EST
Feb 5, 2024 8:00am EST
Jan 4, 2024 8:00am EST
Stay informed and receive company updates straight to your inbox.